Protein biomarker signatures of preeclampsia - a longitudinal 5000-multiplex proteomics study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Protein biomarker signatures of preeclampsia - a longitudinal 5000-multiplex proteomics study ; volume:14 ; number:1 ; day:10 ; month:10 ; year:2024 ; pages:1-14 ; date:12.2024
Scientific reports ; 14, Heft 1 (10.10.2024), 1-14, 12.2024
- Creator
-
Degnes, Maren-Helene Langeland
Westerberg, Ane Cecilie
Andresen, Ina Jungersen
Henriksen, Tore
Roland, Marie Cecilie Paasche
Zucknick, Manuela
Michelsen, Trond Melbye
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-73796-9
- URN
-
urn:nbn:de:101:1-2412272104387.082276720757
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Degnes, Maren-Helene Langeland
- Westerberg, Ane Cecilie
- Andresen, Ina Jungersen
- Henriksen, Tore
- Roland, Marie Cecilie Paasche
- Zucknick, Manuela
- Michelsen, Trond Melbye
- SpringerLink (Online service)
Other Objects (12)
Revisiting biomarker discovery by plasma proteomics
Proteomics reveals unique plasma signatures in constitutional thinness
Myeloperoxidase is not a good biomarker for preeclampsia prediction
Applications of urinary proteomics in biomarker discovery
Multiplex serum biomarker assessments: technical and biostatistical issues
Quantitative shotgun proteomics distinguishes wound-healing biomarker signatures in common carp skin mucus in response to Ichthyophthirius multifiliis
Lipidomic signatures in patients with early-onset and late-onset Preeclampsia
Maximizing biomarker discovery by minimizing gene signatures
Prediction of late-onset preeclampsia using plasma proteomics: a longitudinal multi-cohort study
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
The Role of Ischemia-modified Albumin as a Biomarker in Preeclampsia
Author Correction: Myeloperoxidase is not a good biomarker for preeclampsia prediction
Revisiting biomarker discovery by plasma proteomics
Proteomics reveals unique plasma signatures in constitutional thinness
Myeloperoxidase is not a good biomarker for preeclampsia prediction
Applications of urinary proteomics in biomarker discovery
Multiplex serum biomarker assessments: technical and biostatistical issues
Quantitative shotgun proteomics distinguishes wound-healing biomarker signatures in common carp skin mucus in response to Ichthyophthirius multifiliis
Lipidomic signatures in patients with early-onset and late-onset Preeclampsia
Maximizing biomarker discovery by minimizing gene signatures
Prediction of late-onset preeclampsia using plasma proteomics: a longitudinal multi-cohort study
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
The Role of Ischemia-modified Albumin as a Biomarker in Preeclampsia
Author Correction: Myeloperoxidase is not a good biomarker for preeclampsia prediction
Revisiting biomarker discovery by plasma proteomics
Proteomics reveals unique plasma signatures in constitutional thinness
Myeloperoxidase is not a good biomarker for preeclampsia prediction
Applications of urinary proteomics in biomarker discovery
Multiplex serum biomarker assessments: technical and biostatistical issues
Quantitative shotgun proteomics distinguishes wound-healing biomarker signatures in common carp skin mucus in response to Ichthyophthirius multifiliis
Lipidomic signatures in patients with early-onset and late-onset Preeclampsia
Maximizing biomarker discovery by minimizing gene signatures
Prediction of late-onset preeclampsia using plasma proteomics: a longitudinal multi-cohort study
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
The Role of Ischemia-modified Albumin as a Biomarker in Preeclampsia